E-LIB Suche - Ergebnisse für: Taphoorn, M. J. B.

1

P09.01.A IMPACT OF TIMING OF ANTISEIZURE MEDICATION WITHDRA..:

van der Meer, P B ; Dirven, L ; Fiocco, M...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii58-ii58 , 2023

Link: https://doi.org/10.1093/..

2

P15.08.A MRI PHENOTYPES OF GLIOBLASTOMAS EARLY AFTER TREATM..:

Schmitz Abecassis, B ; Dirven, L ; Jiang, J...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii111-ii111 , 2023

Link: https://doi.org/10.1093/..

3

P11.07.A PERFUSION-MRI BASED DIFFERENTIATION BETWEEN EARLY ..:

Croese, R J I ; van Dorth, D ; Jiang, F...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii73-ii73 , 2023

Link: https://doi.org/10.1093/..

4

P09.06.B The effectiveness of antiepileptic drug triplether..:

van der Meer, P B ; Dirven, L ; Fiocco, M...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii47-ii48 , 2022

Link: https://doi.org/10.1093/..

5

P11.69.B IDH1/2wildtype gliomas grade 2 and 3 with molecula..:

van Opijnen, M P ; Tesileanu, C M S ; Dirven, L...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii74-ii74 , 2022

Link: https://doi.org/10.1093/..

6

PL02.4.A International validation study of an EORTC instrum..:

Oort, Q ; Koekkoek, J ; Aaronson, N K...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii3-ii3 , 2022

Link: https://doi.org/10.1093/..

7

P15.12.A Amine CEST contrast in gliomas to measure metaboli..:

Abecassis Schmitz, B ; Ercan, E ; de Bresser, J...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii86-ii86 , 2022

Link: https://doi.org/10.1093/..

8

P15.06.B Influence of arterial transit time delays on the d..:

van Dorth, D ; Jiang, J ; Schmitz-Abecassis, B...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii85-ii85 , 2022

Link: https://doi.org/10.1093/..

9

P09.04 T2 hyperintense regions on MRI in gliomas: a compari..:

Schmitz-Abecassis, B ; van Osch, M J P ; Dirven, L...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii27-ii27 , 2021

Link: https://doi.org/10.1093/..

10

P14.01 Incidence and impact of venous thromboembolism and m..:

Kaptein, F H J ; Stals, M A M ; Klaase, E...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii38-ii38 , 2021

Link: https://doi.org/10.1093/..

11

OS09.4.A Health-related quality of life in low-grade glioma..:

Boele, F W ; Reijneveld, J C ; de Witt Hamer, P C...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii12-ii12 , 2021

Link: https://doi.org/10.1093/..

12

OS10.8.A The effectiveness of antiepileptic drug duotherapi..:

van der Meer, P B ; Dirven, L ; Fiocco, M...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii14-ii14 , 2021

Link: https://doi.org/10.1093/..

13

P14.49 Prescription preferences of antiepileptic drugs in b..:

van der Meer, P B ; Dirven, L ; van den Bent, M J...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii47-ii47 , 2021

Link: https://doi.org/10.1093/..

14

P04.10 CDKN2A mutational status is associated with venous t..:

Kapteijn, M Y ; Kaptein, F H J ; Stals, M A M...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii20-ii21 , 2021

Link: https://doi.org/10.1093/..

15

P12.01 The effectiveness of antiepileptic drug treatment in..:

van Opijnen, M P ; van der Meer, P B ; Dirven, L...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii30-ii30 , 2021

Link: https://doi.org/10.1093/..